Literature DB >> 15630442

A protective role for the A1 adenosine receptor in adenosine-dependent pulmonary injury.

Chun-Xiao Sun1, Hays W Young, Jose G Molina, Jonathan B Volmer, Jurgen Schnermann, Michael R Blackburn.   

Abstract

Adenosine is a signaling nucleoside that has been implicated in the regulation of asthma and chronic obstructive pulmonary disease. Adenosine signaling can serve both pro- and anti-inflammatory functions in tissues and cells. In this study we examined the contribution of A(1) adenosine receptor (A(1)AR) signaling to the pulmonary inflammation and injury seen in adenosine deaminase-deficient (ADA-deficient) mice, which exhibit elevated adenosine levels. Experiments revealed that transcript levels for the A(1)AR were elevated in the lungs of ADA-deficient mice, in which expression was localized predominantly to alveolar macrophages. Genetic removal of the A(1)AR from ADA-deficient mice resulted in enhanced pulmonary inflammation along with increased mucus metaplasia and alveolar destruction. These changes were associated with the exaggerated expression of the Th2 cytokines IL-4 and IL-13 in the lungs, together with increased expression of chemokines and matrix metalloproteinases. These findings demonstrate that the A(1)AR plays an anti-inflammatory and/or protective role in the pulmonary phenotype seen in ADA-deficient mice, which suggests that A(1)AR signaling may serve to regulate the severity of pulmonary inflammation and remodeling seen in chronic lung diseases by controlling the levels of important mediators of pulmonary inflammation and damage.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15630442      PMCID: PMC539198          DOI: 10.1172/JCI22656

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  55 in total

1.  Adenosine-induced bronchoconstriction in asthma: role of mast cell-mediator release.

Authors:  M J Cushley; S T Holgate
Journal:  J Allergy Clin Immunol       Date:  1985-02       Impact factor: 10.793

2.  Nedocromil sodium is more potent than sodium cromoglycate against AMP-induced bronchoconstriction in atopic asthmatic subjects.

Authors:  R Richards; G D Phillips; S T Holgate
Journal:  Clin Exp Allergy       Date:  1989-05       Impact factor: 5.018

3.  A3 adenosine receptor signaling contributes to airway inflammation and mucus production in adenosine deaminase-deficient mice.

Authors:  Hays W J Young; Jose G Molina; Dawn Dimina; Hongyan Zhong; Marlene Jacobson; Lee-Nien L Chan; Teh-Sheng Chan; James J Lee; Michael R Blackburn
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

4.  Smad3 null mice develop airspace enlargement and are resistant to TGF-beta-mediated pulmonary fibrosis.

Authors:  Philippe Bonniaud; Martin Kolb; Tom Galt; Jennifer Robertson; Clinton Robbins; Martin Stampfli; Carol Lavery; Peter J Margetts; Anita B Roberts; Jack Gauldie
Journal:  J Immunol       Date:  2004-08-01       Impact factor: 5.422

5.  Up-regulation of IL-4 production by the activated cAMP/cAMP-dependent protein kinase (protein kinase A) pathway in CD3/CD28-stimulated naive T cells.

Authors:  Koji Tokoyoda; Kazutake Tsujikawa; Hiroaki Matsushita; Yuichi Ono; Tamon Hayashi; Yohsuke Harada; Ryo Abe; Masato Kubo; Hiroshi Yamamoto
Journal:  Int Immunol       Date:  2004-04-05       Impact factor: 4.823

6.  A1 adenosine receptor knockout mice exhibit increased renal injury following ischemia and reperfusion.

Authors:  H Thomas Lee; Hua Xu; Samih H Nasr; Jurgen Schnermann; Charles W Emala
Journal:  Am J Physiol Renal Physiol       Date:  2003-11-04

7.  Adenosine-activated mast cells induce IgE synthesis by B lymphocytes: an A2B-mediated process involving Th2 cytokines IL-4 and IL-13 with implications for asthma.

Authors:  Sergey Ryzhov; Anna E Goldstein; Anton Matafonov; Dewan Zeng; Italo Biaggioni; Igor Feoktistov
Journal:  J Immunol       Date:  2004-06-15       Impact factor: 5.422

8.  A1 adenosine receptor upregulation and activation attenuates neuroinflammation and demyelination in a model of multiple sclerosis.

Authors:  Shigeki Tsutsui; Jurgen Schnermann; Farshid Noorbakhsh; Scot Henry; V Wee Yong; Brent W Winston; Kenneth Warren; Christopher Power
Journal:  J Neurosci       Date:  2004-02-11       Impact factor: 6.167

Review 9.  Adenosine: an endogenous regulator of innate immunity.

Authors:  György Haskó; Bruce N Cronstein
Journal:  Trends Immunol       Date:  2004-01       Impact factor: 16.687

10.  Elastase secretion by stimulated macrophages. Characterization and regulation.

Authors:  Z Werb; S Gordon
Journal:  J Exp Med       Date:  1975-08-01       Impact factor: 14.307

View more
  49 in total

1.  Signaling through the A2B adenosine receptor dampens endotoxin-induced acute lung injury.

Authors:  Ulrich Schingnitz; Katherine Hartmann; Christopher F Macmanus; Tobias Eckle; Stephanie Zug; Sean P Colgan; Holger K Eltzschig
Journal:  J Immunol       Date:  2010-03-26       Impact factor: 5.422

Review 2.  Beneficial and detrimental role of adenosine signaling in diseases and therapy.

Authors:  Hong Liu; Yang Xia
Journal:  J Appl Physiol (1985)       Date:  2015-08-27

Review 3.  The Purinergic System as a Pharmacological Target for the Treatment of Immune-Mediated Inflammatory Diseases.

Authors:  Luca Antonioli; Corrado Blandizzi; Pál Pacher; György Haskó
Journal:  Pharmacol Rev       Date:  2019-07       Impact factor: 25.468

4.  Structure-activity relationships of new 1H-imidazo[4,5-c]quinolin-4-amine derivatives as allosteric enhancers of the A3 adenosine receptor.

Authors:  Anikó Göblyös; Zhan-Guo Gao; Johannes Brussee; Roberto Connestari; Sabrina Neves Santiago; Kai Ye; Adriaan P Ijzerman; Kenneth A Jacobson
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

Review 5.  Adenosine receptors as therapeutic targets.

Authors:  Kenneth A Jacobson; Zhan-Guo Gao
Journal:  Nat Rev Drug Discov       Date:  2006-03       Impact factor: 84.694

Review 6.  Adenosine receptors and asthma.

Authors:  R A Brown; D Spina; C P Page
Journal:  Br J Pharmacol       Date:  2008-03       Impact factor: 8.739

Review 7.  Adenosine signaling and the regulation of chronic lung disease.

Authors:  Yang Zhou; Daniel J Schneider; Michael R Blackburn
Journal:  Pharmacol Ther       Date:  2009-05-05       Impact factor: 12.310

8.  Enhanced airway inflammation and remodeling in adenosine deaminase-deficient mice lacking the A2B adenosine receptor.

Authors:  Yang Zhou; Amir Mohsenin; Eva Morschl; Hays W J Young; Jose G Molina; Wenbin Ma; Chun-Xiao Sun; Hector Martinez-Valdez; Michael R Blackburn
Journal:  J Immunol       Date:  2009-06-15       Impact factor: 5.422

9.  Sustained adenosine exposure causes lung endothelial barrier dysfunction via nucleoside transporter-mediated signaling.

Authors:  Qing Lu; Julie Newton; Vivian Hsiao; Paul Shamirian; Michael R Blackburn; Mesias Pedroza
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-28       Impact factor: 6.914

Review 10.  Adenosine receptors and asthma in humans.

Authors:  C N Wilson
Journal:  Br J Pharmacol       Date:  2008-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.